APA (7th ed.) Citation

C, R., MP, R., MJ, V., A, T., C, S., A, T., . . . MT, D. (2025). Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial). BMJ open, 15(9), e097802. https://doi.org/10.1136/bmjopen-2024-097802

Chicago Style (17th ed.) Citation

C, Rauber, et al. "Protocol: Faecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/bevacizumab - a Multicentre, Randomised, Placebo-controlled, Double-blind Phase II Trial (the FLORA Trial)." BMJ Open 15, no. 9 (2025): e097802. https://doi.org/10.1136/bmjopen-2024-097802.

MLA (9th ed.) Citation

C, Rauber, et al. "Protocol: Faecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/bevacizumab - a Multicentre, Randomised, Placebo-controlled, Double-blind Phase II Trial (the FLORA Trial)." BMJ Open, vol. 15, no. 9, 2025, p. e097802, https://doi.org/10.1136/bmjopen-2024-097802.